# Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

> **NCT01825330** · NA · COMPLETED · sponsor: **Neuronix Ltd** · enrollment: 131 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DEVICE:** TMS and cognitive stimulation
- **DEVICE:** sham

## Key facts

- **NCT ID:** NCT01825330
- **Lead sponsor:** Neuronix Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825330, "Effect of NeuroAD on the Cognitive Function of Alzheimer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01825330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*